Evidence map›Paper›PMID 24139497›Full record

Trial reportThe Journal of allergy and clinical immunology2014

Childhood asthma clusters and response to therapy in clinical trials.

Timothy S Chang, Robert F Lemanske, David T Mauger, Anne M Fitzpatrick, Christine A Sorkness, Stanley J Szefler, Ronald E Gangnon, C David Page, Daniel J Jackson, Childhood Asthma Research and Education (CARE) Network Investigators

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Article
  3. MicroRNA clustering in pediatric asthma reveals differential corticosteroid responsiveness.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  4. Asthma Phenotypes and Biomarkers.Respiratory care · 2025
    Review
  5. Review
  6. Review
  7. Phenotypes and Endotypes in Asthma.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Treating severe asthma: Targeting the IL-5 pathway.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Expression of corticosteroid-regulated genes by PBMCs in children with asthma.The Journal of allergy and clinical immunology · 2019
    Article
  16. Blood Biomarkers of Sensitization and Asthma.Frontiers in pediatrics · 2019
    Review
  17. Article
  18. Review
  19. Review
  20. Asthma phenotypes in inner-city children.The Journal of allergy and clinical immunology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Timothy S ChangDepartment of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Robert F LemanskeDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
David T MaugerDepartment of Health Evaluation Sciences, Pennsylvania State University, Hershey, Pa.
Anne M FitzpatrickDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Ga.
Christine A SorknessDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Stanley J SzeflerDepartment of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver, Colo.
Ronald E GangnonDepartment of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
C David PageDepartment of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Daniel J JacksonDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: djj@medicine.wisc.edu.
Childhood Asthma Research and Education (CARE) Network Investigators

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
ZUNI KIDNEY PROJECT STUDY I--POPULATION BASED SURVEY OF RENAL DISEASEM01RR000997 · NCRR · UNIVERSITY OF NEW MEXICO · PI LARSON, RICHARD S · 1985 to 2010
$30.0M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI POLONSKY, KENNETH S · 1985 to 2007
$25.4M
PEDIATRIC ASTHMA NETWORK DATA COORDINATING CENTERU10HL064313 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAUGER, DAVID T. · 1999 to 2008
$18.3M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICSU10HL064307 · NHLBI · UNIVERSITY OF ARIZONA · PI MARTINEZ, FERNANDO D · 1999 to 2008
$9.0M
EARLY INTERVENTION IN CHILDHOOD ASTHMAU10HL064288 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 1999 to 2008
$6.7M
Institutional Clinical and Translational Science AwardKL2TR000428 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$6.2M
NCATS NIH HHS KL2 TR000428NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1TR000427NCATS NIH HHS UL1 TR001082NCRR NIH HHS 1UL1RR025011NCRR NIH HHS 5M01 RR00997NCRR NIH HHS 5UL1RR02499204NCRR NIH HHS M01 RR000036NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR00036NCRR NIH HHS M01 RR00051NCRR NIH HHS M01 RR000997NCRR NIH HHS UL1 RR025011NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1RR025780NHLBI NIH HHS 5U10HL064287NHLBI NIH HHS 5U10HL064288NHLBI NIH HHS 5U10HL064295NHLBI NIH HHS 5U10HL064305NHLBI NIH HHS 5U10HL064307NHLBI NIH HHS 5U10HL064313NHLBI NIH HHS F30 HL112491NHLBI NIH HHS F30HL112491NHLBI NIH HHS U10 HL064287NHLBI NIH HHS U10 HL064288NHLBI NIH HHS U10 HL064295NHLBI NIH HHS U10 HL064305NHLBI NIH HHS U10 HL064307NHLBI NIH HHS U10 HL064313NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

backgroundChildhood asthma clusters, or subclasses, have been developed by computational methods without evaluation of clinical utility.

objectiveTo replicate and determine whether childhood asthma clusters previously identified computationally in the Severe Asthma Research Program (SARP) are associated with treatment responses in Childhood Asthma Research and Education (CARE) Network clinical trials.

methodsA cluster assignment model was determined by using SARP participant data. A total of 611 participants 6 to 18 years old from 3 CARE trials were assigned to SARP pediatric clusters. Primary and secondary outcomes were analyzed by cluster in each trial.

resultsCARE participants were assigned to SARP clusters with high accuracy. Baseline characteristics were similar between SARP and CARE children of the same cluster. Treatment response in CARE trials was generally similar across clusters. However, with the caveat of a smaller sample size, children in the early-onset/severe-lung function cluster had best response with fluticasone/salmeterol (64% vs 23% 2.5× fluticasone and 13% fluticasone/montelukast in the Best ADd-on Therapy Giving Effective Responses trial; P = .011) and children in the early-onset/comorbidity cluster had the least clinical efficacy to treatments (eg, -0.076% change in FEV1 in the Characterizing Response to Leukotriene Receptor Antagonist and Inhaled Corticosteroid trial).

conclusionsIn this study, we replicated SARP pediatric asthma clusters by using a separate, large clinical trials network. Early-onset/severe-lung function and early-onset/comorbidity clusters were associated with differential and limited response to therapy, respectively. Further prospective study of therapeutic response by cluster could provide new insights into childhood asthma treatment.

Indexed as

AcetatesAdolescentAdrenergic beta-2 Receptor AgonistsAlbuterolAndrostadienesAnti-Asthmatic AgentsAsthmaBronchodilator AgentsChildCross-Over StudiesCyclopropanesDouble-Blind MethodDrug CombinationsFemaleFluticasoneFluticasone-Salmeterol Drug CombinationAcetatesAdrenergic beta-2 Receptor AgonistsAlbuterolAndrostadienesAnti-Asthmatic AgentsBronchodilator AgentsCyclopropanesDrug CombinationsFluticasoneFluticasone-Salmeterol Drug CombinationLeukotriene AntagonistsmontelukastQuinolinesSulfidesAsthmaBADGERBest ADd-on Therapy Giving Effective ResponsesCARECharacterizing Response to Leukotriene Receptor Antagonist and Inhaled CorticosteroidChildhood Asthma Research and EducationCLICclinical trialsclusteringLDALinear discriminant analysisPACTpediatricPediatric Asthma Controller TrialQDAQuadratic discriminant analysisreplicationSARPSevere Asthma Research Programtherapy response

Identifiers

PMID24139497
PMCPMC3960405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.